Majority of countries in bloc say law would prevent shortages of critical medicines

EU states push for law to limit dependency on drug ingredients from China

A majority of EU member states are pushing for legislation to address shortages of critical drugs and to reduce dependency on imported chemicals from China and other countries.
In a paper seen by the Financial Times, Belgium and 18 other countries — including Germany and France — have gone further than Brussels’ recent proposals to overhaul the bloc’s pharmaceuticals laws, calling for a “last-resort” mechanism to swap medicines between member states and the establishment of a list of critical drugs whose supply chains must be monitored.
This story originally appeared on: Financial Times - Author:Donato Paolo Mancini